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ABSTRACT
In this project, we developed a Western blotting procedure to semi-quantitate levels of 11β HSD1 and 11β-HSD2 in whole cell extracts. Then, we applied this technique to analyze the
effect of reduced maternal aldosterone levels on the expression of 11β-HSD1 and 11β-HSD2
isoenzymes in the placental tissue in both normal and hypertensive rats. These enzymes control
levels of glucocorticoids which compete for aldosterone’s mineralocorticoid receptor.
Overstimulation of this receptor results in hypertension. If aldosterone levels decrease, levels of
the enzymes controlling active glucocorticoid concentrations might change to compensate for the
lowered aldosterone levels. Decreased placental 11β-HSD2 expression could affect
hypertension in the offspring. The Western blotting procedure was optimized for the detection
of the two isoenzymes in their dimeric forms. The use of multiple protein levels on the blot was
useful to obtain a more reliable semi-quantitation. Because of the presence of multiple bands, it
was impossible to use an internal beta actin standard to normalize the data from one blot to
another. This along with the low expression levels and uneven blot backgrounds made it
difficult to obtain enough data on the expression of the two isoenzymes. Very limited data do
not support differences in the placental expression of the two isoenzymes when maternal
aldosterone levels are lowered.
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INTRODUCTION
The enzymes 11-β HSD1 and HSD2 are very important in steroid hormone metabolism.
The roles of 11β-HSD1 and 11β-HSD2 are to interconvert cortisol and the inactive
glucocorticoid, cortisone in humans. They also convert corticosterone and 11dehydrocorticosterone in rodents [Gomez-Sanchez, 2003]. There are two different forms of the
enzyme 11β-HSD.

The first one, 11β− HSD1 acts as an oxidoreductase to form the active

glucocorticoid cortisol or corticosterone in rats. The second isoform is 11β- HSD2 which
produces inactive 11-keto metabolites. The reactions for the isoenzymes are given in Figure 1 on
the next page.
Active glucocorticoids increase the synthesis of glucose and its storage polysaccharide
form, glycogen. Because they can bind to the mineralocorticoid receptor, they can act like
aldosterone and increase the absorption of sodium ions. Therefore, it is important to have
sufficient 11-β HSD2 activity in the placentas to protect against high levels of maternal active
glucocorticoids [Staud, 2006].

If excessive amounts of maternal corticosteroids accumulate in

the fetal tissues, this can lead to higher risks for hypertension and other diseases in adulthood
[Struwe, 2007].
This study addresses a related problem. If maternal aldosterone levels are decreased
through cryodestruction of adrenal glands, will this lower active maternal glucocorticoid levels
and subsequently affect placental levels of the HSD enzymes? Which of the two HSD placental
enzymes are affected and in what way? If the lowering of maternal aldosterone levels decreases
hypertension in the mother, is this programmed into the offspring? What is the role of the HSD
isoenzymes in these mechanisms? This study is part of larger study currently being done by Dr.
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Knoblich and co-workers. They are studying the hormonal and blood pressure effects of
lowering maternal aldosterone, and this study is designed to look at the enzymatic effects.

Figure 1. Reactions of the HSD isoenzymes
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The 11β-HSD1 enzyme catalyzes the largest production of active glucocorticoids from
inactive 11-keto metabolites and many of these reactions occur in the liver microsomes [Lloyd,
1999].

It generally uses NADPH to carry out the reduction reaction to produce active

glucocorticoids ( Figure 1). However, it is also capable of catalyzing the reverse reaction. The
molecular weight of the monomer unit is approximately 31.9 kDa. Because this enzyme is a
glycosylated protein, the masses may vary [Dotsch, 2002]. Limited evidence exists for the active
dimer forms which are capable of showing positive cooperativity in their kinetic properties
[Maser, 2002].
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The 11 β-HSD1 enzyme is also produced in the rat kidney where there are high amounts
present. It is unclear what its role is in human kidney although recent studies support a
dehydrogenase function [Gong, 2008].
The second of the isoenzymes is 11β-HSD2. This enzyme is considered unidirectional as
a dehydrogenase using the coenzyme NAD+. It inactivates the glucocorticoids through their
oxidation (Figure 1). The molecular weight of the monomer unit is approximately 43.7 kDa.
There are limited studies which suggest that this isoenzyme may also dimerize because of
oxidation creating disulfide linkages, but unlike HSD1, it becomes inactive in this dimer form.
[Gomez-Sanchez, 2001]
A summary comparing the two isoenzymes is given in Table 1 below:
Table 1. A Comparison of the 11B-HSD Isoenzymes
11Β-HSD 1
31.9 kDa (varies with glycosylation)
Functions bi-directionally
Can act as a reductase with NADPH
to produce active glucocorticoids
Can act as an oxidase to
produce inactive glucocorticoids
Liver and kidney, placenta, others

11Β-HSD 2
43.7 kDa
Functions unidirectionally
Acts an oxidase with NAD+ to
produce inactive glucocorticoids
Allows aldosterone access to
mineralocorticoid receptor
Kidney and liver, placenta, others

These two enzymes are important in controlling active glucocorticoid levels. The active
glucocorticoids can compete with the hormone aldosterone for the mineralcorticoid receptor.
Either of the two hormones can bind to the mineralcorticoid receptor (MR) leading to the
transcription and translation of the sodium ion channel protein and the sodium/potassium
ATPase. The net effect of this hormonal cascade is to increase sodium reabsorption and to
increase hypertension [Bocchi, 2003].

HSD2 is known to function in the kidney to inactivate

cortisol or corticosterone (See Figure 2 below.) and prevent hypertension which could result
from the glucocorticoids occupying the MR. [Lloyd, 1999].
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Figure 2. Hormonal Mechanisms at the Mineralcorticoid Receptor

Placental 11β-HSD2 protects the fetus from the high circulating levels of the maternal
glucocorticoids. When the cortisol crosses the placenta of the animal it becomes inactivated and
doesn’t hurt the growing embryo. In rodents 11β-HSD2 expression is very high and is related to
fetal weight at midgestation, but drops dramatically toward the end of the term [Krozowski,
1999]. Chronic stress in the maternal rats does not allow for increased 11β-HSD2 activity
although acute stress near term did increase levels of the enzyme to protect the fetus from
increased levels of maternal corticosterone [Welberg, 2005].
11 β -HSD2 also plays a role in hormonal programming. When fetal and placental 11 β HSD2 levels are insufficient, this can promote hypertension in adulthood [Fujisawa, 2004]. The
offspring of rats treated with synthetic glucocorticoid, dexamethasone, during late pregnancy had
lower birth weights than offspring of control rats and were shown to increase their expression of
11β -HSD1 [Wan, 2005 ]. The results of these experiments indicated that 11β-HSD1 plays a
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critical role in the control of normal fetal growth and the subsequent development of adult
disease.
In another study, diabetes was drug induced in pregnant normotensive rats and the
maternal corticosterone levels were reduced [Fujisawa, 2004].

The researchers found that 11β -

HSD 2 mRNAs decreased significantly in the experimental placentas and fetal kidneys. Because
diabetic mothers are known to imprint high blood pressure in their offspring, the authors
suggested that this may be due in part to the lowered expression of the HSD2 enzyme.
Other studies suggest that there is a correlation between hypertension in adulthood and
embryo growth restriction in the human womb. In their study, Struwe and coworkers [2007] not
only found that 11β-HSD2 gene expression was reduced in placentae of smaller than normal
neonates, there was also a corresponding decrease in the expression of 11β-HSD1 gene
expression. The authors speculated that this could be a possible mechanism to counteract the
loss of inactivation of the cortisol hormone because of lowered amounts of HSD2.
This is work is part of a larger study by Dr. Knoblich and researchers, who are using
cryodestruction of the outer layer of the maternal adrenal gland to lower aldosterone levels and
measure hypertension in the offspring. Because the programming is known to occur in the fetus
and because HSD placental enzymes control active glucocorticoid levels, their expressions were
measured in both normotensive and hypertensive rat placentas. To accomplish this, the
feasibility of using a Western blotting technique to semiquantitate HSD isoenzymes from whole
cell extracts (not microsomes) was examined. Then, the methods were used to measure the
expression of the HSD isoenzymes in the placentae of rats with lowered aldosterone levels.

.
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MATERIALS AND METHODS
Treatment of the rats
Four to five week old rats were fasted for 16 hours before surgery. Under anesthesia,
the right adrenal gland was removed in the experimental rats. The left adrenal gland was frozen
using a metal spatula dipped in liquid nitrogen, with each area of the gland’s surface frozen three
times in succession. Control rats underwent a mock or sham surgery with the identical incisions,
but no removal or freezing procedures were done on the adrenals. This part of the project was
conducted by Dr. Knoblich and her students and has IRB approval.
Isolation of placental tissue
The rats were mated after a recovery period and placentas were removed by Dr.
Knoblich on the 20th day of gestation. They were washed in saline and cut in quarters followed
by quick freezing in liquid nitrogen. They were stored in a -80 freezer.
Isolation of the crude protein extracts
The rat placentas were frozen in liquid nitrogen and then ground to a powder and
weighed out to give 100 mg of frozen tissue. The frozen powder was mixed with 4 volumes of
extraction buffer which consisted of 25mM Tris-HCl, pH 8.0, 200mM Sucrose, 154mM KCl,
and 20mM DTT. The protein was then vortexed for 3 minutes with a one minute rest in
between. The mixture was then centrifuged for 15 minutes at 10,000 x g. The crude protein
extract was then diluted into Laemmli sample buffer to give a final concentration of 300mM
DTT and 1.3% SDS. Four different concentrations of protein in the range of approximately .52.5 mg/ml were prepared. The samples were heated for 6 minutes at 100 degree C and 20 ul of
sample was quantitatively applied to respective wells.
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Gel Electrophoresis and Blotting
The sample mixtures were run on a 12.5% Laemmli gel (BIO-RAD Criterion),
equilibrated in 1X Laemmli Buffer, at 35 milliamps for a half hour and then at 40 milliamps for
two hours and twenty minutes. The gels were blotted on to polyvinyl-difluoride (PVDF)
membranes. The blotting was run in 1X Towbin containing 20% methanol at 85 volts for 75
minutes. The membranes were taken out and placed in a blocking solution consisting of 4%
bovine serum albumin (BSA) in a 1X Tris buffered saline, pH 8.0 (TBST) solution containing
.10 % Tween 20 and then agitated for 60 minutes. The primary antibodies to HSD1 and HSD2
(Santa Cruz no. 20175 and 20176, respectively ), were put onto the gels at a dilution of 1:1000
in blocking buffer, and were agitated for 15 minutes and then put into a cold room overnight.
The following morning they were agitated for one more hour at room temperature.
The gels were then washed in a 1X TBST solution 8 times for 5 minutes each. The
secondary antibody (conjugated to peroxidase) was diluted into blocking buffer, at a dilution of
1:120,000. The membranes were then agitated for an additional 60 minutes. The membranes
were then washed again 8 times for 5 minutes with the 1X TBST. The membranes were then
soaked in 6.5- 7.0 ml of the SuperSignal West Femto Maximum Sensitivity substrate (Pierce) for
5 minutes. They were then put onto clear transparency films and sealed with all air bubbles
being removed. The membranes were then developed using ECL film for 2- 5 seconds.
Determination of protein concentrations and protein band sizes
The Kaleidoscope protein standards (BIO-RAD) were used to obtain a standard curve for
molecular weights and to estimate the size of the major protein bands on the blot.
The Bradford assay (BIO-RAD) was used to determine the ug of protein in each well.
An average of four samples was taken and BSA was used as the protein for the standard curve.
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Semi-quantitation of the HSD isoenzymes
The developed film was quantitated using a Hoeffer densitometer and the areas under the
peaks were determined using Gaussian integration. The width of the lane was measured and
used to normalize the sample areas. These areas were then plotted against the ug of protein used.
Line equations were then used to determine the total area for 50ug of protein and the error
associated with the number could be estimated from the line fit.

RESULTS
I.Optimization of the Blot
The HSD isoenzymes are not abundant proteins. Most western blots in the literature
represent the analyses of microsomal extracts. Because of time and equipment restrictions, this
project attempted to use whole cell extracts along with a very sensitive chemiluminescent
substrate to detect these relatively rare enzymes.
Several blots were run initially to optimize conditions. The extraction buffer and
secondary antibody concentrations as well as the blocking protein were varied. Also, 10%
polyacrylamide gels were compared to 12.5% gels for the best resolution of protein bands. The
optimal conditions are given in the materials and methods. Beta actin was initially used for an
internal standard. However, because of the multiple bands seen with the other antibodies, it was
difficult to detect so its use had to be discontinued. Unfortunately, without the use of an internal
standard to normalize the areas, it was impossible to compare the numbers among blots.
None of the conditions gave major bands at the desired molecular weights. Multiple
bands were seen but the major bands present were a 68kD protein on the HSD1 film and a band

Published by Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University, Mankato, 2008

9

Journal of Undergraduate Research at Minnesota State University, Mankato, Vol. 8 [2008], Art. 5

representing a 78kD protein on the HSD2 film (Figure 3). The HSD 2 film also showed a major
68 kD protein. This was disturbing since the sequence comparison in the region to which the
antibody was directed was not highly homologous between the two isoenzymes. However,
insufficient funds did not allow for the purchase of additional primary antibodies.
Analysis of adult kidney and liver samples showed multiple bands as well with different
molecular weights. Some of the variability can be due to processing and glycosylation
differences in different tissues. Because of the literature documentation of dimerization in older
samples, it was assumed that the dimer forms at 68 kDa and 78 kDa represented HSD 1 and HSD
2 and since these could be quantitated in all blots, these were the bands which were analyzed.

Figure 3. Samples Blots of Placental Crude Extracts
A. Blot using HSD1 primary Ab

68kDa-

B. Blot using HSD2 primary Ab

78kDa-

II.A comparison of HSD 1 and HSD 2 levels in the treated vs. control WKY samples
A limited number of WKY samples were tested for HSD1 and HSD2 protein expression
(Table 2). The results of blot 1 showed no significant differences and those of blot 2 suggest a
decrease in HSD 1 expression in the experimental placentae. However, one of the experimental

https://cornerstone.lib.mnsu.edu/jur/vol8/iss1/5

10

Jorissen: The Effect of Maternal Aldosterone Levels on the Expression of 11

samples (J) does not show a significantly reduced maternal aldosterone level. Therefore, the
very limited preliminary data do not support differences in the expression of the HSD1 enzyme.

Table 2. A Comparison of HSD 1 Expression in Control vs. Experimental WKY Placentas
Control
WKY Sample
D (20.9)
G (10.7)
average

HSD 1 area
19559 ± 7260
15084 ± 1365
17321 ± 4312

Experimental
WKY Sample
B (4.72)
F (39.5)
average

Blot 2

E (21.6)
A (10.3)
average

15678 ± 1390
11931 ± 1550
13804 ± 1470

I (2.92)
J (19.3)
average

Blot 4

DD(15.0)

Blot 1

6732 ± 7269

BB (1.25)

HSD 1 area
23967 ± 4868
18623 ± 1130
21295 ± 2999
6027 ± 370
8873 ± 2584
7450 ± 1477
30102 ± 4540

Numbers in parentheses represent aldosterone levels in ng/dl (Knoblich, personal communication)

In blot 1, when HSD2 protein expressions were compared, there were no significant
differences (Table 3). In blot 2 there appears to be a decrease in the expression of HSD2 in the
experimental samples. However, sample J does not show a reduced maternal aldosterone level.
Therefore, the limited preliminary data do not support differences in the expression of the HSD2
enzyme in the placentae of WKY rats with lowered aldosterone levels.

Table 3. A Comparison of HSD2 Expression in Control vs. Experimental WKY Placentae

Blot 1

Control
WKY Sample
D (20.9)
G (10.7)
average

HSD 2 area
12914 ± 8739
2727 ± 719
7820 ± 4729

Experimental
WKY Sample
B (4.70)
F (39.5)
average

HSD 2 area
5921 ± 836
4066 ± 160
4993 ± 498

Blot 2

E (21.6)
A (10.3)
average

5041 ± 2115
3491 ± 913
4266 ± 1514

I (2.92)
J (19.3)
average

1420 ± 86
1791 ± 187
1605 ± 136

Blot 4

DD (15.0)

9588 ± 4428

BB (1.25)

7430 ± 1209

Numbers in parentheses represent aldosterone levels in ng/dl (Knoblich, personal communication)
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III. A comparison of HSD 1 and HSD 2 levels in the treated vs. control SHR samples
The results for the SHR samples (Tables 4 and 5) showed no significant change in the
protein expression of either isoenzyme. The error and the inadequate number of experimental
samples, with reduced maternal aldosterone levels, made it difficult to develop any conclusions.

Table 4. A Comparison of HSD1 Expression in Control vs. Experimental SHR Placentas.
HSD 1 area

Blot 3

Control
SHR Sample
M (13.4)
O (19.5)
average

HSD1 area

24740 ± 19548
11720 ± 3615
18230 ± 11581

Experimental
SHR Sample
S (15.2)
N (3.46)
average

Blot 4

Q (14.4)

10171 ± 1445

T (3.35)

14856 ± 3450

9367 ± 1112
18870 ± 2231
14118 ± 1671

Numbers in parentheses represent aldosterone levels in ng/dl (Knoblich, personal communication)

Table 5. A Comparison of HSD2 Expression in Control vs. Experimental SHR Placentas.
HSD 2 area

Blot 3

Control
SHR Sample
M (13.4)
O (19.5)
average

Blot 4

Q (14.4)

16100 ± 1506

1596 ± 170
4075 ± 2037
2785 ± 1103

Experimental
SHR Sample
S (15.2)
N (3.46)
average

HSD 2 area

T (3.35)

15063 ± 2324

4341 ± 924
4753 ± 1521
4547 ± 1222

Numbers in parentheses represent aldosterone levels in ng/dl (Knoblich, personal communication)

DISCUSSION
The limitations of western blotting as a quantitative tool were evident in this project.
When the background was uneven or bubbles occurred in the blot, it made quantitation difficult
and the error values were high. The use of multiple concentrations helped but limited the
number of samples which could be analyzed. The lack of the internal standard made it
impossible to average sample numbers from one set of blots to the next. Because of variability
in the rat data, this was a serious limitation in the design and needs to be corrected before further
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studies are conducted. Better primary antibodies may solve this problem. The only affordable
primary antibodies were polyclonal and gave multiple bands.
The presence of the dimers has been previously documented in the literature. It would be
useful to verify with another source of primary antibody. It may be that cytosolic forms of the
enzyme exist in precursor or dimer forms or that aging of the samples causes crosslinks that
cannot be disrupted by a reducing agent.
The best approach to measure expression changes may be the measurement of messenger
RNA (mRNA) levels using reverse transcription and quantitative polymerase chain reaction (RTqPCR). This technology will soon become available at MSU with the purchase of a real time
PCR instrument. However, this technique cannot measure changes in expression which occur
later at the protein level.

ACKNOWLEDGEMENTS
The authors wish to thank Dr. Knoblich and her students for the opportunity to
collaborate in this hypertension project. They especially acknowledge the treatment of the rats
and the removal of the placental tissue and providing the hormonal data. The authors gratefully
acknowledge support from the McNair Program and a URC foundation grant. Technical
assistance for some of the Bradford analysis and sample and blot preparations was provided by
Kristina Dittrich. The authors wish to thank Dr. Jim Rife for his technical support especially in
the preparation of the samples and the development of the film.

Published by Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University, Mankato, 2008

13

Journal of Undergraduate Research at Minnesota State University, Mankato, Vol. 8 [2008], Art. 5

REFERENCES

Bocchi, B., Fagart, J., Cluzeaud, F., Fay, M., Rafestin-Oblin, M. E., & Farman, N. (2003)
Glucocorticoid metabolism by 11-B hydroxysteroid dehydrogenase type 2 modulates human
mineralocorticoid receptor transactivation activity. Journal of Steroid Biochemistry and
Molecular Biology 84, 239-244.
Dotsch, J., & Wolfgang, R. (2002) The role of 11B-hydroxysteroid dehydrogenase activity in the
metabolic syndrome: lessons learned from the animal model. European Journal of
Endocrinology 146, 603-605.
Fujisawa, Y., Nakagawa, Y., Ren-shan, L., Ohzeki, T. (2004) Streptozotocin-induced diabetes in
the pregnant rat reduces 11 beta-hydroxysteroid dehydrogenase type 2 expression in the
placenta and fetal kidney. Life Sciences 75, 2797-2805.
Gomez-Sanchez, E. P., Ganjam, V., Chen, Y. J., Liu, Y., Clark, S.A., Gomez-Sanchez, C.E.
(2001) The 11B hydroxysteroid dehydrogenase 2 exists as an inactive dimer. Steroids 66, 845848.
Gong, R., Morris, D.J., Brem, A.S. (2008) Human Renal 11-B-Hydroxysteroid Dehydrogenase
1 functions and colocalizes with COX-2 Life Sciences 82, 631-637.
Krozowski, Z., Li, K.X.Z., Koyama, K., Smith, R. E., Obeyesekere, V.R., Stein-Oakley, A.,
Sasano, H. (1999) The type I and type II 11B-hydroxysteroid dehydrogenase enzymes. Journal
of Steroid Biochemistry and Molecular Biology 69,391-401.
Lloyd, S. A., Nelson, S. M., Florin, M., Lo, M., McKinnell, J., Sassard, J., Kenyon, C. J. (1999)
11B-Hydroxysteroid Dehydrogenase and Corticosteroid Action in Lyon Hypertensive Rats.
American Heart Association, 1123-1128.
Maser, E., Volker, B., Friebertshauser, J. (2002) 11B-Hydroxysteroid Dehydrogenase Type 1
from Human Liver: Dimerization and Enzyme Cooperativity Support Its Postulated Role as
Glucocorticoid Reductase Biochemistry 41, 2459-2465.
Struwe, E., Berzl, G., Schild, R.L., Beckmann, M.W., Dorr, H.G., Rascher, W., Dotsch, J. (2007)
Simultaneously reduced gene expression of cortisol-activating and cortisol-inactivating enzymes
in placentas of small-for-gestational age neonates. Am J Obstet Gynecol 197, 43-44.
Staud, F., Mazancova, K., Miksik, I., Pavek, P., Fendrich, Z., Pacha, J. (2006) Corticosterone
Transfer and Metabolism in the Dually Perfused Rat Placenta: Effect of 11B-hydroxysteroid
Dehydrogenase Type 2. Placenta 27, 171-180.
Wan, S., Hao, R., Sun, K. (2005) Repeated maternal dexamethasone treatments in late gestation
increases 11B-hydroxysteroid dehydrogenase type 1 expression in the hippocampus of the
newborn rat Neuroscience Letters 382, 96-101.

https://cornerstone.lib.mnsu.edu/jur/vol8/iss1/5

14

Jorissen: The Effect of Maternal Aldosterone Levels on the Expression of 11

Welberg, L.A. M., Thrivikraman, K.V., Plotsky, P.M. Chronic maternal stress inhibits the
capacity to up-regulate placental 11B-hydroxysteroid dehydrogenase type 2 activity (2005)
Journal of Endocrinology 186, R7-R12.

Student Biography: Nicole Jorissen
Nicole Jorissen is currently a junior at Minnesota State University, Mankato studying
Biochemistry. She is involved in several clubs on campus and is the treasurer of the MSU Chem
Club on campus. She also does work study with the Chemistry faculty and works in the labs
most time gaining experience that will be helpful for grad school. She plans to attend Purdue or
the University of Pennsylvania in the fall of 2010. She hopes to obtain her PhD. in molecular
genetics with an emphasis in biochemical reactions. She is also a current McNair scholar and
has presented at two national conferences. She recently presented at the NCUR conference in
MD and the URC conference at MSU Mankato. She currently resides in Mankato, MN.

Mentor Biography: Terry Salerno
Dr. Terry Salerno received an A.B. degree in Biochemistry from Mt. Holyoke College
and a Ph.D degree in Biochemistry from the University of Wisconsin, Madison. She has been a
professor at Minnesota State University since the fall of 1986 where her primary course
responsibilities are allied health chemistry and the biochemistry courses. In the last ten years she
has mentored several undergraduate research students. She has collaborated with Dr. Rife and
Dr. Knoblich on the study of HSD isoenzymes for the past couple of years. This is the first
project to study expression at the protein level.

Published by Cornerstone: A Collection of Scholarly and Creative Works for Minnesota State University, Mankato, 2008

15

